SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
|
|
|
FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If the drug gets approved by the FDA, it is estimated to achieve Peak sales of $350 million. To read about our ex...
... more »
|
|
|
|
|
FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If the drug gets approved by the FDA, it is estimated to achieve Peak sales of $350 million. To read about our ex...
... more »
|
|
|
|
|
Upcoming FDA decision on a BDSI's drug Onsolis for Pain is expected on July 10th. The decision was expected on June 12th but FDA pushed back the decision. To read about our opinion on whether Onsolis will be approved or not, along with details of the drug, the disease, the other player in this area, ...
... more »
|
|
|
|
|
ONE OF A HALF DOZEN BIOTECH STOCK TO OWN AND HAVE IN YOUR PORTFOLIO.
... more »
|
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on BDSI |
Visit streetinsider.com
More Resources
|